We obtained the maximum likelihood and Bayes estimators of the parameters of the generalized inverted exponential distribution in case of the progressive type-II censoring scheme with binomial removals. Bayesian estimation procedure has been discussed under the consideration of the square error and general entropy loss functions while the model parameters follow the gamma prior distributions. The performances of the maximum likelihood and Bayes estimators are compared in terms of their risks through the simulation study. Further, we have also derived the expression of the expected experiment time to get a progressively censored sample with binomial removals, consisting of specified number of observations from generalized inverted exponential distribution. An illustrative example based on a real data set has also been given.
This paper aims to estimate the stress-strength reliability parameter R = P (Y < X), when X and Y are independent inverted exponential random variable. We have also disscused some fundamental properties of the considered distribution. The maximum likelihood estimator (MLE) of R and its asymptotic distribution are obtained. The Bayesian estimation of the reliability parameter has been also discussed under the assumption of independent gamma prior. Numerical integration technique is used for Bayesian computation. The proposed estimators are compared in terms of their mean squared errors through the simulation study. Two real data sets representing survival of head and neck cancer patients are fitted using the inverted exponential distribution and used to estimate the stress-strength parameters and reliability.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.